查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1760639

結核病全球市場報告（2025年）

Mycobacterium Tuberculosis Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

預計未來幾年結核病市場規模將強勁成長。到2029年，該市場規模將達到45.7億美元，複合年成長率為5.2%。預測期內的成長預計將受到以下因素的推動：全球結核病病患病率的上升、全球抗藥性結核病發病率的上升、人們對結核病傳播和預防意識的增強、政府為消除結核病而採取的舉措和投入，以及結核病治療研發的不斷增加。預測期內的主要趨勢包括結核病診斷技術的發展、快速結核病檢測的普及、新型結核病疫苗的推出、耐多藥結核病新藥物方案的開發以及結核病藥物製劑的創新。

預計結核病市場的成長將受到研發投入增加的推動。研發 (R&D) 涉及透過系統的研究和實驗創造新知識或改進現有產品、服務和技術。技術的快速進步推動著研發投資的增加，因此需要不斷創新才能在全球市場上保持競爭力。研發透過發現能夠克服目前治療方法抗藥性的候選藥物來提高治療效果和患者預後，從而為結核病治療做出貢獻。例如，2024 年 3 月，英國政府宣佈為 TB REACH 計畫提供 500 萬美元（400 萬英鎊）的資金，該計畫旨在支持創新策略，以改善中低收入國家對結核病的診斷和治療。該計劃可以為 50 萬人提供醫療保健，發現 37,000 例結核病，並挽救超過 15,000 人的生命。因此，增加研發投資將推動結核病市場的成長。

結核病市場中的公司正專注於開發先進的解決方案，例如自動化結核病檢測，以提供更快、更準確的診斷。自動化結核病檢測是一種診斷工具，它使用自動化系統和先進技術，在最少的人為干預下快速準確地檢測結核病細菌和抗藥性。例如，2025 年 4 月，美國生技公司 Revvity Inc. 宣布，美國食品藥物管理局(FDA) 已核准其 Autopure 2400 液體處理平台和 T-SPOT 結核病檢測。 Autopure 2400 平台與 T-SPOT.TB 檢測的整合透過實現大容量處理並保持準確性，改善了自動化結核病檢測。該平台結合了液體處理和磁性細胞分離技術，每次檢測最多可檢測 24 個檢體，第一天的檢測在 3.5 小時內完成，並且只需最少的用戶參與。 T-SPOT.TB 檢測被 WHO 認可為唯一基於 ELISPOT 的 IGRA，可確保結果可重複，不確定結果更少，減少重新檢測的需要，並為免疫力缺乏的患者提供可靠的性能。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場宏觀經濟情境：包括利率、通貨膨脹、地緣政治、貿易戰、關稅以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球結核病市場：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素、限制因素）
  • 最終用途產業分析
  • 全球結核病市場：成長率分析
  • 全球結核病市場規模及成長率：實際成果值，2019-2024
  • 全球結核病市場規模及成長率：預測（2024-2029 年、2034 年）
  • 全球結核病市場：總可用市場（TAM）

第6章市場區隔

  • 全球結核病市場依產品類型、實際成果值及預測值，2019-2024 年、2024-2029 年、2034 年
  • 裝置
  • 試劑和耗材
  • 軟體解決方案
  • 全球結核病市場依診斷方法、實際成果值及預測值，2019-2024 年、2024-2029 年、2034 年
  • 基於文化的診斷
  • 分子診斷
  • 免疫學檢測
  • 全球結核病市場依給藥途徑、實際成果值及預測值（2019-2024 年、2024-2029 年、2034 年）
  • 口服藥物
  • 注射
  • 全球結核病市場（按最終用戶、實際成果值和預測值）2019-2024 年、2024-2029 年、2034 年
  • 醫院
  • 診斷實驗室
  • 研究所
  • 全球結核病市場按設備類型、實際成果值和預測值，2019-2024 年、2024-2029 年、2034 年
  • 診斷設備
  • 檢測設備
  • 分子診斷設備
  • 結核病培養系統
  • 全球結核病市場按試劑和耗材類型、實際成果值和預測值（2019-2024 年、2024-2029 年和 2034 年）
  • 聚合酵素鏈鎖反應（PCR）試劑
  • 結核菌培養基
  • 抗原試劑套件
  • 測試條
  • 結核病診斷試劑套件
  • 全球結核病市場（按軟體解決方案類型、實際成果值和預測值），2019-2024 年、2024-2029 年、2034 年
  • 實驗室資訊管理系統（LIMS）
  • 診斷軟體
  • 資料管理軟體
  • 結核病診斷的遠端醫療解決方案

第7章 區域和國家分析

  • 全球結核病市場各地區實際成果值值及預測值（2019-2024、2024-2029、2034）
  • 全球結核病市場（按國家/地區分類）、實際成果值和預測值（2019-2024 年、2024-2029 年、2034 年）

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章競爭格局與公司概況

  • 結核病市場：競爭格局
  • 結核病市場：公司簡介
    • F. Hoffmann-La Roche Ltd.（概況、產品與服務、策略、財務分析）
    • 賽默飛世爾科技公司（概況、產品與服務、策略、財務分析）
    • 雅培實驗室（概況、產品與服務、策略、財務分析）
    • 諾華公司（概況、產品與服務、策略、財務分析）
    • 碧迪公司（概況、產品與服務、策略、財務分析）

第31章 其他大型創新企業

  • Viatris Inc.
  • Macleods Pharmaceuticals Limited
  • bioMerieux SA
  • Bio-Rad Laboratories Inc.
  • Bruker Corporation
  • QIAGEN NV
  • Lupin Limited
  • Zydus Cadila Healthcare Limited
  • Cepheid Inc.
  • Serum Institute of India Pvt. Ltd.
  • Oxford Immunotec USA Inc.
  • Panacea Biotec Limited
  • International AIDS Vaccine Initiative Inc.
  • HiMedia Laboratories Private Limited
  • Akonni Biosystems Inc.

第 32 章全球市場：競爭基準化分析板

第33章 重大企業合併（M&A）

第34章近期市場趨勢

第35章：具有高市場潛力的國家、產業與策略

  • 結核病市場：提供新機會的國家（2029年）
  • 結核病市場：提供新機會的領域（2029）
  • 結核病市場：成長策略（2029年）
    • 基於市場趨勢的策略
    • 競爭策略

第36章 附錄

簡介目錄
Product Code: r35516

Mycobacterium tuberculosis is a slow-growing, rod-shaped bacterium that primarily targets the lungs, although it can also affect other body parts. It is the pathogen responsible for tuberculosis (TB), a contagious disease transmitted through airborne droplets when an infected person coughs, sneezes, or speaks. The bacterium has a distinct, waxy cell wall made of mycolic acid, which provides resistance to drying and helps it persist in the environment.

The primary product types associated with Mycobacterium tuberculosis include instruments, reagents and consumables, and software solutions. Instruments refer to the medical devices and equipment used for diagnosing and researching TB. Diagnosis can be achieved through various techniques, such as culture-based methods, molecular testing, and immunological assays, with administration routes being either oral or injectable. These products are used by various end users, including hospitals, diagnostic labs, and research institutions.

The mycobacterium tuberculosis market research report is one of a series of new reports from The Business Research Company that provides mycobacterium tuberculosis market statistics, including mycobacterium tuberculosis industry global market size, regional shares, competitors with a mycobacterium tuberculosis market share, detailed mycobacterium tuberculosis market segments, market trends and opportunities, and any further data you may need to thrive in the mycobacterium tuberculosis industry. This mycobacterium tuberculosis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The mycobacterium tuberculosis market size has grown strongly in recent years. It will grow from $3.54 billion in 2024 to $3.74 billion in 2025 at a compound annual growth rate (CAGR) of 5.5%. The growth during the historic period can be attributed to the rising number of TB cases in high-burden countries, increased funding from international organizations, the expansion of TB screening programs, a higher incidence of TB-HIV co-infections, and the growth in global travel and migration, which have contributed to the spread of TB.

The mycobacterium tuberculosis market size is expected to see strong growth in the next few years. It will grow to $4.57 billion in 2029 at a compound annual growth rate (CAGR) of 5.2%. The growth during the forecast period is expected to be driven by the increasing prevalence of TB worldwide, the rising global incidence of drug-resistant TB, heightened awareness about TB transmission and prevention, government initiatives and funding for TB elimination, and increased research and development efforts focused on TB treatment. Key trends in the forecast period include advances in TB diagnostic technologies, the availability of rapid TB testing methods, the introduction of new TB vaccines, the development of new drug regimens for multidrug-resistant TB, and technological innovations in TB drug formulation.

The growth of the mycobacterium tuberculosis market is expected to be driven by increased investments in research and development. Research and development (R&D) involves the creation of new knowledge or the improvement of existing products, services, or technologies through systematic investigation and experimentation. The rising investment in R&D is fueled by rapid technological advancements, creating the need for constant innovation to remain competitive in the global market. R&D contributes to mycobacterium tuberculosis treatment by discovering novel drug candidates capable of overcoming resistance to current therapies, thus enhancing treatment efficacy and patient outcomes. For example, in March 2024, the UK government announced a $5 million (£4 million) funding boost for the TB REACH program, aimed at supporting innovative strategies for improving tuberculosis diagnosis and treatment in low- and middle-income countries. This initiative will provide healthcare to 500,000 people, help detect TB in 37,000 individuals, and potentially save more than 15,000 lives. As a result, the increased investment in R&D is set to drive the growth of the mycobacterium tuberculosis market.

Companies in the mycobacterium tuberculosis market are focusing on developing advanced solutions such as automated tuberculosis tests to provide faster, more accurate diagnoses. Automated tuberculosis tests are diagnostic tools that use automated systems and advanced technologies to rapidly and accurately detect Mycobacterium tuberculosis and drug resistance, with minimal human intervention. For instance, in April 2025, Revvity Inc., a US-based biotechnology company, announced that the U.S. Food and Drug Administration (FDA) approved the Auto-Pure 2400 liquid handling platform with the T-SPOT TB test. The integration of the Auto-Pure 2400 platform with the T-SPOT.TB test improves automated tuberculosis testing by enabling higher-volume processing while maintaining accuracy. This platform combines liquid handling and magnetic cell isolation technologies, testing up to 24 samples per run, completing Day 1 of testing in under 3.5 hours, and requiring minimal user involvement. The T-SPOT.TB test, recognized by the WHO as the only ELISPOT-based IGRA, ensures reproducible results with fewer indeterminate outcomes, reduces the need for repeat testing, and provides reliable performance for immunocompromised patients.

In November 2023, Becton Dickinson and Company (BD), a US-based provider of tuberculosis diagnostics, collaborated with Bio Farma to help Indonesia eliminate the spread of tuberculosis. This partnership aims to enhance access to BD's innovative TB diagnostics portfolio and improve the TB solutions supply chain in Indonesia. It also offers Bio Farma the opportunity to deepen its expertise in the development of diagnostic kits. Bio Farma is an Indonesia-based manufacturer of tuberculosis vaccines.

Major players in the mycobacterium tuberculosis market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Novartis AG, Becton Dickinson and Company, Viatris Inc., Macleods Pharmaceuticals Limited, bioMerieux SA, Bio-Rad Laboratories Inc., Bruker Corporation, QIAGEN N.V., Lupin Limited, Zydus Cadila Healthcare Limited, Cepheid Inc., Serum Institute of India Pvt. Ltd., Oxford Immunotec USA Inc., Panacea Biotec Limited, International AIDS Vaccine Initiative Inc., HiMedia Laboratories Private Limited, and Akonni Biosystems Inc.

North America was the largest region in the mycobacterium tuberculosis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in mycobacterium tuberculosis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the mycobacterium tuberculosis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The mycobacterium tuberculosis market consists of revenues earned by entities by providing services such as tuberculosis strain typing and genotyping services, contract research services, biorepository services, and genomic sequencing services. The market value includes the value of related goods sold by the service provider or included within the service offering. The mycobacterium tuberculosis market also includes sales of diagnostic kits, antibodies, antigens, recombinant proteins, nucleic acid extraction kits, and biosafety equipment. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Mycobacterium Tuberculosis Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on mycobacterium tuberculosis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for mycobacterium tuberculosis ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The mycobacterium tuberculosis market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product Type: Instruments; Reagents And Consumables; Software Solutions
  • 2) By Diagnostic Method: Culture-Based Methods; Molecular Diagnosis; Immunological Tests
  • 3) By Route Of Administration: Oral; Injectable
  • 4) By End User: Hospitals; Diagnostic Laboratories; Research Institutions
  • Subsegments:
  • 1) By Instruments: Diagnostic Instruments; Detection Instruments; Molecular Diagnostic Instruments; Tuberculosis Culture Systems
  • 2) By Reagents And Consumables: Polymerase Chain Reaction Reagents; Tuberculosis Culture Media; Antigen Kits; Test Strips; Tuberculosis Diagnostic Kits
  • 3) By Software Solutions: Laboratory Information Management Systems (LIMS); Diagnostic Software; Data Management Software; Telemedicine Solutions for TB Diagnosis
  • Companies Mentioned: F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific Inc.; Abbott Laboratories; Novartis AG; Becton Dickinson and Company
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Mycobacterium Tuberculosis Market Characteristics

3. Mycobacterium Tuberculosis Market Trends And Strategies

4. Mycobacterium Tuberculosis Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Mycobacterium Tuberculosis Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Mycobacterium Tuberculosis PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Mycobacterium Tuberculosis Market Growth Rate Analysis
  • 5.4. Global Mycobacterium Tuberculosis Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Mycobacterium Tuberculosis Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Mycobacterium Tuberculosis Total Addressable Market (TAM)

6. Mycobacterium Tuberculosis Market Segmentation

  • 6.1. Global Mycobacterium Tuberculosis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Instruments
  • Reagents And Consumables
  • Software Solutions
  • 6.2. Global Mycobacterium Tuberculosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Culture-Based Methods
  • Molecular Diagnosis
  • Immunological Tests
  • 6.3. Global Mycobacterium Tuberculosis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Oral
  • Injectable
  • 6.4. Global Mycobacterium Tuberculosis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Diagnostic Laboratories
  • Research Institutions
  • 6.5. Global Mycobacterium Tuberculosis Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Diagnostic Instruments
  • Detection Instruments
  • Molecular Diagnostic Instruments
  • Tuberculosis Culture Systems
  • 6.6. Global Mycobacterium Tuberculosis Market, Sub-Segmentation Of Reagents And Consumables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Polymerase Chain Reaction Reagents
  • Tuberculosis Culture Media
  • Antigen Kits
  • Test Strips
  • Tuberculosis Diagnostic Kits
  • 6.7. Global Mycobacterium Tuberculosis Market, Sub-Segmentation Of Software Solutions, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Laboratory Information Management Systems (LIMS)
  • Diagnostic Software
  • Data Management Software
  • Telemedicine Solutions for TB Diagnosis

7. Mycobacterium Tuberculosis Market Regional And Country Analysis

  • 7.1. Global Mycobacterium Tuberculosis Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Mycobacterium Tuberculosis Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Mycobacterium Tuberculosis Market

  • 8.1. Asia-Pacific Mycobacterium Tuberculosis Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Mycobacterium Tuberculosis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Mycobacterium Tuberculosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Mycobacterium Tuberculosis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Mycobacterium Tuberculosis Market

  • 9.1. China Mycobacterium Tuberculosis Market Overview
  • 9.2. China Mycobacterium Tuberculosis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Mycobacterium Tuberculosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Mycobacterium Tuberculosis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Mycobacterium Tuberculosis Market

  • 10.1. India Mycobacterium Tuberculosis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Mycobacterium Tuberculosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Mycobacterium Tuberculosis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Mycobacterium Tuberculosis Market

  • 11.1. Japan Mycobacterium Tuberculosis Market Overview
  • 11.2. Japan Mycobacterium Tuberculosis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Mycobacterium Tuberculosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Mycobacterium Tuberculosis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Mycobacterium Tuberculosis Market

  • 12.1. Australia Mycobacterium Tuberculosis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Mycobacterium Tuberculosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Mycobacterium Tuberculosis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Mycobacterium Tuberculosis Market

  • 13.1. Indonesia Mycobacterium Tuberculosis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Mycobacterium Tuberculosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Mycobacterium Tuberculosis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Mycobacterium Tuberculosis Market

  • 14.1. South Korea Mycobacterium Tuberculosis Market Overview
  • 14.2. South Korea Mycobacterium Tuberculosis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Mycobacterium Tuberculosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Mycobacterium Tuberculosis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Mycobacterium Tuberculosis Market

  • 15.1. Western Europe Mycobacterium Tuberculosis Market Overview
  • 15.2. Western Europe Mycobacterium Tuberculosis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Mycobacterium Tuberculosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Mycobacterium Tuberculosis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Mycobacterium Tuberculosis Market

  • 16.1. UK Mycobacterium Tuberculosis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Mycobacterium Tuberculosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Mycobacterium Tuberculosis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Mycobacterium Tuberculosis Market

  • 17.1. Germany Mycobacterium Tuberculosis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Mycobacterium Tuberculosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Mycobacterium Tuberculosis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Mycobacterium Tuberculosis Market

  • 18.1. France Mycobacterium Tuberculosis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Mycobacterium Tuberculosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Mycobacterium Tuberculosis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Mycobacterium Tuberculosis Market

  • 19.1. Italy Mycobacterium Tuberculosis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Mycobacterium Tuberculosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Mycobacterium Tuberculosis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Mycobacterium Tuberculosis Market

  • 20.1. Spain Mycobacterium Tuberculosis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Mycobacterium Tuberculosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Mycobacterium Tuberculosis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Mycobacterium Tuberculosis Market

  • 21.1. Eastern Europe Mycobacterium Tuberculosis Market Overview
  • 21.2. Eastern Europe Mycobacterium Tuberculosis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Mycobacterium Tuberculosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Mycobacterium Tuberculosis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Mycobacterium Tuberculosis Market

  • 22.1. Russia Mycobacterium Tuberculosis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Mycobacterium Tuberculosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Mycobacterium Tuberculosis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Mycobacterium Tuberculosis Market

  • 23.1. North America Mycobacterium Tuberculosis Market Overview
  • 23.2. North America Mycobacterium Tuberculosis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Mycobacterium Tuberculosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Mycobacterium Tuberculosis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Mycobacterium Tuberculosis Market

  • 24.1. USA Mycobacterium Tuberculosis Market Overview
  • 24.2. USA Mycobacterium Tuberculosis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Mycobacterium Tuberculosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Mycobacterium Tuberculosis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Mycobacterium Tuberculosis Market

  • 25.1. Canada Mycobacterium Tuberculosis Market Overview
  • 25.2. Canada Mycobacterium Tuberculosis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Mycobacterium Tuberculosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Mycobacterium Tuberculosis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Mycobacterium Tuberculosis Market

  • 26.1. South America Mycobacterium Tuberculosis Market Overview
  • 26.2. South America Mycobacterium Tuberculosis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Mycobacterium Tuberculosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Mycobacterium Tuberculosis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Mycobacterium Tuberculosis Market

  • 27.1. Brazil Mycobacterium Tuberculosis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Mycobacterium Tuberculosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Mycobacterium Tuberculosis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Mycobacterium Tuberculosis Market

  • 28.1. Middle East Mycobacterium Tuberculosis Market Overview
  • 28.2. Middle East Mycobacterium Tuberculosis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Mycobacterium Tuberculosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Mycobacterium Tuberculosis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Mycobacterium Tuberculosis Market

  • 29.1. Africa Mycobacterium Tuberculosis Market Overview
  • 29.2. Africa Mycobacterium Tuberculosis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Mycobacterium Tuberculosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Mycobacterium Tuberculosis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Mycobacterium Tuberculosis Market Competitive Landscape And Company Profiles

  • 30.1. Mycobacterium Tuberculosis Market Competitive Landscape
  • 30.2. Mycobacterium Tuberculosis Market Company Profiles
    • 30.2.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis

31. Mycobacterium Tuberculosis Market Other Major And Innovative Companies

  • 31.1. Viatris Inc.
  • 31.2. Macleods Pharmaceuticals Limited
  • 31.3. bioMerieux SA
  • 31.4. Bio-Rad Laboratories Inc.
  • 31.5. Bruker Corporation
  • 31.6. QIAGEN N.V.
  • 31.7. Lupin Limited
  • 31.8. Zydus Cadila Healthcare Limited
  • 31.9. Cepheid Inc.
  • 31.10. Serum Institute of India Pvt. Ltd.
  • 31.11. Oxford Immunotec USA Inc.
  • 31.12. Panacea Biotec Limited
  • 31.13. International AIDS Vaccine Initiative Inc.
  • 31.14. HiMedia Laboratories Private Limited
  • 31.15. Akonni Biosystems Inc.

32. Global Mycobacterium Tuberculosis Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Mycobacterium Tuberculosis Market

34. Recent Developments In The Mycobacterium Tuberculosis Market

35. Mycobacterium Tuberculosis Market High Potential Countries, Segments and Strategies

  • 35.1 Mycobacterium Tuberculosis Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Mycobacterium Tuberculosis Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Mycobacterium Tuberculosis Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer